Related references
Note: Only part of the references are listed.Clinical features of silent corticotroph adenomas
Hussein Alahmadi et al.
ACTA NEUROCHIRURGICA (2012)
Clinicopathological Correlations in Pituitary Adenomas
Ozgur Mete et al.
BRAIN PATHOLOGY (2012)
The molecular pathogenesis of corticotroph tumours
Dorota Dworakowska et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Biomarkers of aggressive pituitary adenomas
Ozgur Mete et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Osteopontin: a potentially important therapeutic target in cancer
Mansoor Ahmed et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis
Toru Tateno et al.
PLOS GENETICS (2011)
The effect of polymorphisms in the promoter region of the MMP-1 gene on the occurrence and invasiveness of hypophyseal adenoma
Murat Altas et al.
ACTA NEUROCHIRURGICA (2010)
Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas
Hwa Young Cho et al.
CLINICAL ENDOCRINOLOGY (2010)
Involvement of osteopontin as a core protein in craniopharyngioma calcification formation
Qi SongTao et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Biomarkers of Pituitary Neoplasms: A Review (Part II)
Fateme Salehi et al.
NEUROSURGERY (2010)
FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex
Nami Sugiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes
Odelia Cooper et al.
Hormones & Cancer (2010)
The Pathogenesis of Pituitary Tumors
Sylvia L. Asa et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
MMP-1 polymorphism and its relationship to pathological processes
P. A. Arakaki et al.
JOURNAL OF BIOSCIENCES (2009)
Osteopontin stimulates invasion of NCI-h295 cells but is not associated with survival in adrenocortical carcinoma
Dirk Weismann et al.
JOURNAL OF PATHOLOGY (2009)
KI-67 IN PITUITARY NEOPLASMS: A REVIEW-PART I
Fateme Salehi et al.
NEUROSURGERY (2009)
Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia
Xuegong Zhu et al.
CLINICAL CANCER RESEARCH (2008)
The Expression of Integrinβ1 and FAK in Pituitary Adenomas and Their Correlation with Invasiveness
Feng Wan et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2008)
Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas
Jian Gong et al.
PITUITARY (2008)
Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas
Koji Morita et al.
CLINICAL ENDOCRINOLOGY (2008)
A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas
Shozo Yamada et al.
NEUROSURGERY (2007)
Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line
Isa M. Hussaini et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Targeting N-cadherin through fibroblast growth factor receptor-4: Distinct pathogenetic and therapeutic implications
Shereen Ezzat et al.
MOLECULAR ENDOCRINOLOGY (2006)
Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells
Zhiyong Mi et al.
CARCINOGENESIS (2006)
Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix
M Paez-Pereda et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas
Weiping Liu et al.
JOURNAL OF MEDICAL INVESTIGATION (2005)
Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions
A Kolb et al.
CANCER BIOLOGY & THERAPY (2005)
Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: Relation to tumor type, size, proliferation, and invasiveness
ZR Qian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells
A Miyoshi et al.
BRITISH JOURNAL OF CANCER (2004)
Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: A mechanism underlying pituitary neoplasia
S Ezzat et al.
MOLECULAR ENDOCRINOLOGY (2004)
Silent corticotroph adenomas: Further clinical and pathological observations
JA Lopez et al.
HUMAN PATHOLOGY (2004)
Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18
AL Omara-Opyene et al.
LABORATORY INVESTIGATION (2004)
Integrins: versatile integrators of extracellular signals
C ffrench-Constant et al.
TRENDS IN CELL BIOLOGY (2004)
Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently
KJ Bradley et al.
CLINICAL ENDOCRINOLOGY (2003)
N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling
U Cavallaro et al.
NATURE CELL BIOLOGY (2001)
Expression and regulation of osteopontin and connective tissue growth factor transcripts in rat anterior pituitary
J Ehrchen et al.
JOURNAL OF ENDOCRINOLOGY (2001)
Characterization and distribution of extracellular matrix components and receptors in GH3B6 prolactin cells
DP Carvalho et al.
BIOLOGY OF THE CELL (2000)
Osteopontin
J Sodek et al.
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE (2000)
Adhesion receptors and cell invasion: mechanisms of integrin-guided degradation of extracellular matrix
J Ivaska et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2000)
High levels of matrix metalloproteinases regulate proliferation and hormone secretion in pituitary cells
MP Pereda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)